FOXP3 and allergic rhinitis: Malmhäll et al. demonstrated that the number of FOXP3+ cells in the nasal mucosa of patients with allergic rhinitis was significantly increased compared with healthy subjects, and that seasonal increases in FOXP3+ cells in nasal biopsy specimens compared with baseline values were observed in both placebo- and immunotherapy-treated patients with grass pollen allergy [3].